天宇股份：公司布立西坦原料药获得CEP证书

Core Viewpoint - Tianyu Co., Ltd. has received the European Pharmacopoeia suitability certification for the active pharmaceutical ingredient Brilinta, indicating compliance with European quality standards and enabling sales in the European market and other markets that recognize the CEP certificate [1] Group 1 - The certification signifies that the active pharmaceutical ingredient meets the quality requirements set by the European Pharmacopoeia [1] - This achievement is expected to positively impact the company's product diversification and international market expansion efforts [1]